Daily Archives: November 3, 2008

Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin’s Lymphoma

Cephalon had an approval announcement today that is worth sharing, not only from the clinical point of view, but from a communications point of view.  It is an example of a smart announcement and one that demonstrates the growing importance … Continue reading

Posted in Approval Announcements | Comments Off